Skip to content

Detachable String Magnetically Controlled Capsule Endoscopy for Completely Viewing of Esophagus and Stomach

A Novel Detachable String Magnetically Controlled Capsule Endoscopy (DS-MCE) for Viewing Esophagus and Stomach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03457909
Enrollment
25
Registered
2018-03-08
Start date
2018-03-07
Completion date
2018-08-01
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatients

Keywords

string, capsule endoscopy

Brief summary

The purpose of the study is to determine the safety and feasibility of the new technique,detachable string magnetically controlled capsule endoscopy(DS-MCE)for evaluating gastric and esophagus diseases.

Detailed description

Esophageal capsule endoscopy(ECE)provides a novel noninvasive approach to visualize the esophagus.The main drawback for the use of ECE is its unreliable transit time which often renders an inadequate visualization of the esophagus.Thus investigators have developed the detachable string magnetically controlled capsule endoscopy(DS-MCE) which can control the movement of the capsule through the string. This study is a prospective, single-centered, self-controlled pilot study.Outpatients who have esophagus symptoms will take conventional endoscopy examination and DS-MCE successively.

Interventions

DEVICEDS-MCE

During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* outpatients who have esophagus symptoms.

Exclusion criteria

* known or suspected complex history of gastrointestinal obstruction, stenosis or fistula. * dysphagia or delayed gastric emptying. * known or suspected possibility of active bleeding of digestive tract. * a history of abdominal operation. * pacemaker implantation and gastrointestinal pacemaker users. * patients who are allergic to simethicone or pronase. * pregnant women,mental patients. * other circumstances that doctors consider inappropriate for the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Successful Separation of Capsule and String, and Complete Viewing of Esophagus and Stomachup to 2 weeksevaluate the feasibility of the novel DS-MCE examination. The successful separation of the capsule and string was evaluated by the capsule entering the stomach and and the string being pulled out.Complete viewing of esophagus and stomach was evaluated by completing the procedure from the capsule being swallowed, the esophagus observed retrograde, to the string being pulled out after separating from the capsule.This primary outcome indicated how many participatns completed the DS-MCE examination successfully.

Secondary

MeasureTime frameDescription
Number of DS-MCE Associated Adverse Eventsup to 2 weeksevaluate the safety of DS-MCE.Record any adverse event during the procedure and after the procedure.Patients will be followed up by telephone to inquire about the symptoms of abdominal distention, abdominal pain,vomiting and other discomfort. Follow up to the end of the capsule expulsion.
Duration of Time Capsule is Within the Esophagusup to 2 weekstime from the capsule swallowed to the capsule entering the gastric cardia to examine the stomach
Z-line Visualizationup to 2 weeksZ-line represents the normal esophagogastric junction where the squamous mucosa of the esophagus and columnar mucosa of the stomach meet.We can devide the Z-line into four quadrants under capsule endoscopy. Observing all the four quadrants is considered to be a complete observation of Z-line. In this study,the number of participants with at least two quadrants of Z-line visualized was used to evaluate the Z-line visulization.
Quality Score of Z-line Imagesup to 2 weeksgrade (mild, moderate,and severe) of air-bubble and saliva interference on the Z-line view(0, no intraluminal gas bubble; 1, a few gas bubbles, no limitation of interpretation; 2, an increased amount of intraluminal foam/gas bubbles, moderate limitation of visibility; 3, an amount of foam/gas bubbles)
Degree of Comfortup to 2 weeksevaluate patient's degree of comfort throughout the procedure.Patients will be asked to fill in a questionnaire to give scores about degree of comfort throughout the procedure.Overall discomfort was scored on a scale of 0 to 10 (0, no discomfort; 10, the overall discomfort of EGD).

Countries

China

Participant flow

Recruitment details

Healthy volunteers or patients with suspected esophageal diseases were prospectively enrolled in Changhai Hospital from March 2018 to June 2018.

Pre-assignment details

This study was a prospective, self-controlled, single-centered pilot study. After enrollment, each enrolled subject first underwent DS-MCE(detachable string magnetically controlled capsule endoscopy), and subsequently EGD(esophagogastroduodenoscopy) within one week.

Participants by arm

ArmCount
DS-MCE
outpatients who have esophagus symptoms will take DS-MCE and conventional endoscopy examination examination successively. DS-MCE: During the DS-MCE examination,the capsule is allowed to travel down into gastric cardia,from where the string is slowly pulled to allow the capsule to view the esophagus retrogradely.
25
Total25

Baseline characteristics

CharacteristicDS-MCE
Age, Continuous54 years
Race and Ethnicity Not Collected— Participants
Region of Enrollment
China
25 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
0 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Number of Participants With Successful Separation of Capsule and String, and Complete Viewing of Esophagus and Stomach

evaluate the feasibility of the novel DS-MCE examination. The successful separation of the capsule and string was evaluated by the capsule entering the stomach and and the string being pulled out.Complete viewing of esophagus and stomach was evaluated by completing the procedure from the capsule being swallowed, the esophagus observed retrograde, to the string being pulled out after separating from the capsule.This primary outcome indicated how many participatns completed the DS-MCE examination successfully.

Time frame: up to 2 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
DS-MCENumber of Participants With Successful Separation of Capsule and String, and Complete Viewing of Esophagus and Stomach25 Participants
Secondary

Degree of Comfort

evaluate patient's degree of comfort throughout the procedure.Patients will be asked to fill in a questionnaire to give scores about degree of comfort throughout the procedure.Overall discomfort was scored on a scale of 0 to 10 (0, no discomfort; 10, the overall discomfort of EGD).

Time frame: up to 2 weeks

ArmMeasureValue (MEAN)
DS-MCEDegree of Comfort0.96 score on a scale
Secondary

Duration of Time Capsule is Within the Esophagus

time from the capsule swallowed to the capsule entering the gastric cardia to examine the stomach

Time frame: up to 2 weeks

ArmMeasureValue (MEDIAN)
DS-MCEDuration of Time Capsule is Within the Esophagus6.2 minutes
Secondary

Number of DS-MCE Associated Adverse Events

evaluate the safety of DS-MCE.Record any adverse event during the procedure and after the procedure.Patients will be followed up by telephone to inquire about the symptoms of abdominal distention, abdominal pain,vomiting and other discomfort. Follow up to the end of the capsule expulsion.

Time frame: up to 2 weeks

ArmMeasureValue (NUMBER)
DS-MCENumber of DS-MCE Associated Adverse Events0 adverse events
Secondary

Quality Score of Z-line Images

grade (mild, moderate,and severe) of air-bubble and saliva interference on the Z-line view(0, no intraluminal gas bubble; 1, a few gas bubbles, no limitation of interpretation; 2, an increased amount of intraluminal foam/gas bubbles, moderate limitation of visibility; 3, an amount of foam/gas bubbles)

Time frame: up to 2 weeks

ArmMeasureValue (MEAN)
DS-MCEQuality Score of Z-line Images0.68 score on a scale
Secondary

Z-line Visualization

Z-line represents the normal esophagogastric junction where the squamous mucosa of the esophagus and columnar mucosa of the stomach meet.We can devide the Z-line into four quadrants under capsule endoscopy. Observing all the four quadrants is considered to be a complete observation of Z-line. In this study,the number of participants with at least two quadrants of Z-line visualized was used to evaluate the Z-line visulization.

Time frame: up to 2 weeks

ArmMeasureValue (NUMBER)
DS-MCEZ-line Visualization20 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026